Expert NetworkExpert InterviewMDGL

Slingshot members are talking to an expert! The topic is:

Exploring the Potential of Madrigal Pharmaceuticals' Resmetirom in Treating NASH: Insights from the Phase 3 MAESTRO-NASH Trial

Executed on:Dec 5, 2023 9:30 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Imperial College London
  • Consultant Hepatologist at Imperial College Healthcare NHS Trust, and Honorary Senior Lecturer at Imperial College London.
  • Leads the NAFLD service in the Trust, overseeing a clinic that cares for more than 600 patients.
  • Research interests are focused in translational aspects of NAFLD care, including prediction of cardiovascular risk, quantitation of liver biopsies from NAFLD patients using machine learning, and management of NAFLD cirrhosis. 

Interview Goal

To delve into the recent findings from the Phase 3 MAESTRO-NASH trial by Madrigal Pharmaceuticals, focusing on the efficacy and safety of Resmetirom in treating nonalcoholic steatohepatitis (NASH), and to understand its potential impact on the future treatment landscape of liver diseases.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.